China Officially Charges GSK Executives, Details Bribery Practices
This article was originally published in PharmAsia News
Executive Summary
China’s Ministry of Public Security has made formal bribery charges against UK-based drug maker GlaxoSmithKline and former general manager Mark Reilly and two Chinese executives for bribing non-government agencies and personnel.